000	02039cam  2200313za 4500
001	9.833931
003	CaOODSP
005	20221107150325
007	cr |||||||||||
008	170327s2016    oncd    os   f000 0 eng d
040	|aCaOODSP|beng
041	0 |aeng|afre
043	|an-cn---
086	1 |aH82-24/2016-PDF
245	00|aCost pressures in the Canadian hospital drug market, 2006-2014 |h[electronic resource] = |bPressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014.
246	31|aPressions sur les coûts du marché pharmaceutique des hôpitaux du Canada, 2006-2014
260	|a[Ottawa] : |bPatented Medicine Prices Review Board, |c[2016]
300	|a[1] p. : |bcol. charts
500	|aCaption title.
500	|aAt head of title: National Prescription Drug Utilization Information System.
520	|a"The sale of drugs dispensed in hospitals represents a relatively small component of the Canadian pharmaceutical market (13%), but is nonetheless an emerging market segment. The rates of growth in drug expenditures for in-patient and out-patient settings in Canada are analyzed in this study and compared to foreign markets, with a focus on the impact of high-cost drugs. The analysis provides policy makers with insight into the cost pressures in the Canadian hospital market and illustrates how it compares internationally to the seven Patented Medicine Prices Review Board comparator countries (PMPRB7: France, Germany, Italy, Sweden, Switzerland, the United Kingdom and the United States)."
546	|aText in English and French.
692	07|2gccst|aHealth care facilities
692	07|2gccst|aDrugs
692	07|2gccst|aPrices
710	1 |aCanada. |bPatented Medicine Prices Review Board.
710	2 |aNational Prescription Drug Utilization Information System (Canada)
792	|tCost pressures in the Canadian hospital drug market, 2006-2014 |w(CaOODSP)9.833932
856	40|qPDF|s356 KB|uhttps://publications.gc.ca/collections/collection_2017/cepmb-pmprb/H82-24-2016.pdf